Dxcover, a Glasgow-based company developing a blood test that can detect cancer at an early stage, has raised £9.7m through a Series A investment round and grant funding. The £7.5m funding round was led by existing investors Eos Advisory LLP, Mercia Asset Management, Scottish Enterprise, University of Strathclyde, SIS Ventures and Norcliffe Capital, which were … Continue reading Cancer blood test firm raises £9.7m